GLP-1 Check — India's GLP-1 Information & Self-Assessment Tool
Updated daily

GLP-1 & Semaglutide News (India)

India-first daily coverage of GLP-1 therapy — DCGI approvals, Indian generic launches (Sundae, Noveltreat, Obeda, Semabest…), price cuts, Mounjaro / tirzepatide updates, and trial readouts (STEP, SUSTAIN, SURMOUNT, SELECT).

200 articles

In India

58 articles
IndiaThe News Mill·about 18 hours ago

GLP-1 medications and skin changes during weight loss in India

GLP-1 medications and skin changes during weight loss in India The News Mill

IndiaThe South First·about 18 hours ago

Fertility runway: How women are being prescribed weight-loss drugs before conception

Fertility runway: How women are being prescribed weight-loss drugs before conception The South First

IndiaThe Economic Times·1 day ago

Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for tho

Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for tho The Economic Times

IndiaBusiness Today·1 day ago

'GLP-1 alters...': Kiran Mazumdar-Shaw sounds caution as Nithin Kamath flags weak drug demand

'GLP-1 alters...': Kiran Mazumdar-Shaw sounds caution as Nithin Kamath flags weak drug demand Business Today

Research & Trials

70 articles
ResearchMen's Fitness·about 24 hours ago

New Trial Shows Oral GLP-1 Aleniglipron May Be the Future

New Trial Shows Oral GLP-1 Aleniglipron May Be the Future Men's Fitness

ResearchNDTV Profit·1 day ago

GLP-1 Debate: Kiran Mazumdar-Shaw Warns Of Long-Term Risks As Nithin Kamath Flags Weak Demand

GLP-1 Debate: Kiran Mazumdar-Shaw Warns Of Long-Term Risks As Nithin Kamath Flags Weak Demand NDTV Profit

ResearchLondon Evening Standard·2 days ago

Think you know how to eat on GLP-1s? You need more than a basic 101…

Think you know how to eat on GLP-1s? You need more than a basic 101… London Evening Standard

ResearchDiabetes In Control·2 days ago

Compounded GLP-1 Clinical Safety: What Every Clinician Should Know

Compounded GLP-1 Clinical Safety: What Every Clinician Should Know Diabetes In Control

Regulation

47 articles
RegulationVera Health·1 day ago

FDA approves new Wegovy (semaglutide) indication to reduce cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and obesity or overweight

FDA approves new Wegovy (semaglutide) indication to reduce cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and obesity or overweight Vera Health

RegulationCardiovascular Business·2 days ago

Americans keep poisoning themselves with semaglutide, other weight loss drugs

Americans keep poisoning themselves with semaglutide, other weight loss drugs Cardiovascular Business

RegulationNews-Medical·2 days ago

Semaglutide approval drove a surge in GLP-1 poison center exposures

Semaglutide approval drove a surge in GLP-1 poison center exposures News-Medical

RegulationStudyFinds·3 days ago

Poison Center Calls For Semaglutide Weight-Loss Drugs More Than Doubled After FDA Approval

Poison Center Calls For Semaglutide Weight-Loss Drugs More Than Doubled After FDA Approval StudyFinds

Global

25 articles
GlobalCBC·4 days ago

Weight-loss drug approved to treat sleep apnea in Canada

Weight-loss drug approved to treat sleep apnea in Canada CBC

GlobalBioSpace·5 days ago

Lilly’s tirzepatide will be biggest blockbuster ever, topping $70B by 2032: Evaluate

Lilly’s tirzepatide will be biggest blockbuster ever, topping $70B by 2032: Evaluate BioSpace

Globalstatnews.com·5 days ago

Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?

Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it? statnews.com

GlobalThe Motley Fool·6 days ago

Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk

Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk The Motley Fool

News articles are aggregated from third-party RSS feeds. GLP-1 Check does not endorse or verify individual articles. Content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment.